Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617
22.10.2024
0:00
30:54
Dr. Ashwin Singh Parihar speaks with Dr. Phillip Kuo, Dr. Andrew Armstrong, and Dr. Ken Herrmann about how 68Ga-PSMA-11 PET can predict response of metastatic prostate cancer following 177Lu-PSMA-617 therapy. The VISION Trial.
Weitere Episoden von „Radiology Podcasts | RSNA“
Verpasse keine Episode von “Radiology Podcasts | RSNA” und abonniere ihn in der kostenlosen GetPodcast App.